Enterovirus A71 (EV-A71) is one of the most popular causative agents of Hand, Foot, and Mouth Disease (HFMD), also the main factor causing several severe symptoms, which can lead to children’s death. Up to now, vaccines and antiviral compounds still have disadvantages and are not widely used. Therefore, finding other alternatives and supplemental solutions is necessary, and virus-trap turns out to be a valuable candidate. The main function of the trap is to capture viruses, thereby preventing the infection. To do this, the trap needs to be constructed by one of the EVA71‘s binding receptors on human cells, and SCARB2 is the potential one. In this study, we cloned, expressed, and purified the recombinant SCARB2, which was fused with foldon peptide to structure the trimeric form with a highly viral-catching ability for virus trap. For the mentioned purposes, vector pET22b-scrb2-IIIx3 was constructed, and transformed into E. coli DH5α. Protein SCRB2-IIIx3 was expressed in E. coli BL21(DE3), but in monomeric form, and mostly in innclusion bodies. After that, it was refolded and purified to soluble form which has biological activity. Those results supportably provide insightful information, which creates a premise for further research.